These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 20133071

  • 1. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
    Rodríguez N, Sanz X, Trampal C, Foro P, Reig A, Lacruz M, Membrive I, Lozano J, Quera J, Algara M.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):659-66. PubMed ID: 20133071
    [Abstract] [Full Text] [Related]

  • 2. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1016-23. PubMed ID: 15979817
    [Abstract] [Full Text] [Related]

  • 3. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):78-86. PubMed ID: 15093902
    [Abstract] [Full Text] [Related]

  • 4. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R, Halama J, Bova D, Sethi A, Emami B.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):720-6. PubMed ID: 17293230
    [Abstract] [Full Text] [Related]

  • 5. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM.
    J Nucl Med; 2005 Aug 01; 46(8):1342-8. PubMed ID: 16085592
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
    Aristophanous M, Berbeco RI, Killoran JH, Yap JT, Sher DJ, Allen AM, Larson E, Chen AB.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e99-105. PubMed ID: 21377285
    [Abstract] [Full Text] [Related]

  • 7. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1432-41. PubMed ID: 16125870
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP, Yu JM, Guo HB, Fu Z, Han AQ, Yang GR.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 01; 29(6):453-6. PubMed ID: 17974282
    [Abstract] [Full Text] [Related]

  • 9. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
    Devic S, Tomic N, Faria S, Menard S, Lisbona R, Lehnert S.
    Int J Radiat Oncol Biol Phys; 2010 Dec 01; 78(5):1555-62. PubMed ID: 20646840
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2009 Jul 01; 50(6):638-44. PubMed ID: 19492198
    [Abstract] [Full Text] [Related]

  • 11. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ.
    Radiother Oncol; 2000 Jun 01; 55(3):317-24. PubMed ID: 10869746
    [Abstract] [Full Text] [Related]

  • 12. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
    Fleckenstein J, Hellwig D, Kremp S, Grgic A, Gröschel A, Kirsch CM, Nestle U, Rübe C.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e283-9. PubMed ID: 21470782
    [Abstract] [Full Text] [Related]

  • 13. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD.
    J Nucl Med; 2006 Nov 15; 47(11):1808-12. PubMed ID: 17079814
    [Abstract] [Full Text] [Related]

  • 14. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.
    Clin Nucl Med; 2010 Apr 15; 35(4):237-43. PubMed ID: 20305410
    [Abstract] [Full Text] [Related]

  • 15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
    Hanna GG, Carson KJ, Lynch T, McAleese J, Cosgrove VP, Eakin RL, Stewart DP, Zatari A, O'Sullivan JM, Hounsell AR.
    Int J Radiat Oncol Biol Phys; 2010 Nov 15; 78(4):1040-51. PubMed ID: 20350798
    [Abstract] [Full Text] [Related]

  • 16. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
    Hanna GG, McAleese J, Carson KJ, Stewart DP, Cosgrove VP, Eakin RL, Zatari A, Lynch T, Jarritt PH, Young VA, O'Sullivan JM, Hounsell AR.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):24-30. PubMed ID: 19665324
    [Abstract] [Full Text] [Related]

  • 17. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M, Kepka L, Dziuk M, Zawadzka A, Szalus N, Gizewska A, Bujko K.
    Int J Radiat Oncol Biol Phys; 2011 Jul 15; 80(4):1008-14. PubMed ID: 20656419
    [Abstract] [Full Text] [Related]

  • 18. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 15; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 19. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
    Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, Cachin F, Berriolo-Riedinger A, Olivier P, Kolesnikov-Gauthier H, Blagosklonov O, Bridji B, Devillers A, Collombier L, Courbon F, Gremillet E, Houzard C, Caignon JM, Roux J, Aide N, Brenot-Rossi I, Doyeux K, Dubray B, Vera P.
    J Nucl Med; 2013 Sep 15; 54(9):1543-50. PubMed ID: 23918733
    [Abstract] [Full Text] [Related]

  • 20. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb 15; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.